Tg Therapeutics (TGTX) Interest & Investment Income (2012 - 2019)
Tg Therapeutics' (TGTX) quarterly Interest & Investment Income came in at $1.1 million in Q2 2019, up 382.96% year-on-year from $223000.0 in Q2 2018, and up 622.82% quarter-over-quarter from $149000.0 in Q1 2019.
Tg Therapeutics (TGTX) Interest & Investment Income (2012 - 2019) Analysis & Trends
Tg Therapeutics' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $1.1 million for Q2 2019.
- On a quarterly basis, Interest & Investment Income rose 382.96% year-over-year to $1.1 million in Q2 2019; TTM through Jun 2019 was $1.8 million, a 208.64% increase from a year earlier, with the FY2018 full-year figure at $857000.0, up 190.51% from the prior year.
- Interest & Investment Income climbed to $1.1 million in Q2 2019 per TGTX's latest filing, from $149000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.1 million in Q2 2019 and bottomed at $22132.0 in Q1 2015.
- The 5-year median for Interest & Investment Income is $86413.5 (2016), against an average of $161647.4.
- Across the five-year window, Interest & Investment Income tumbled 46.97% in 2017 and surged 382.96% in 2019, its largest moves.
- Year by year, Interest & Investment Income stood at $64993.0 in 2015, then decreased by 11.46% to $57544.0 in 2016, then soared by 110.27% to $121000.0 in 2017, then soared by 119.83% to $266000.0 in 2018, then surged by 304.89% to $1.1 million in 2019.
- Per Business Quant, the three latest TGTX Interest & Investment Income figures stand at $1.1 million (Q2 2019), $149000.0 (Q1 2019), and $266000.0 (Q4 2018).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Tg Therapeutics | 8.10 Bn | 8.03 Bn | 171.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 1.08 Mn |
| Mar 31, 2019 | 149,000.00 |
| Dec 31, 2018 | 266,000.00 |
| Sep 30, 2018 | 258,000.00 |
| Jun 30, 2018 | 223,000.00 |
| Mar 31, 2018 | 144,000.00 |
| Dec 31, 2017 | 121,000.00 |
| Sep 30, 2017 | 79,000.00 |
| Jun 30, 2017 | 50,000.00 |
| Mar 31, 2017 | 45,000.00 |
| Dec 31, 2016 | 57,544.00 |
| Sep 30, 2016 | 87,965.00 |
| Jun 30, 2016 | 92,629.00 |
| Mar 31, 2016 | 84,862.00 |
| Dec 31, 2015 | 64,993.00 |
| Sep 30, 2015 | 55,977.00 |
| Jun 30, 2015 | 31,551.00 |
| Mar 31, 2015 | 22,132.00 |
| Dec 31, 2014 | 16,741.00 |
| Sep 30, 2014 | 12,107.00 |